eGDR May Accurately Predict Renal Function Among Patients With T2DM
Investigators assessed the predictive value of estimated glucose disposal rate on renal outcomes among patients with type 2 diabetes mellitus.
Diagnosis & Disease Information
Rapid Kidney Function Decline Linked With Increased Heart Failure Risk in T2DM
An investigation explored associations between rapid kidney function decline and increased heart failure risk in individuals with type 2 diabetes.
Rapid Kidney Function Decline Linked With Increased Heart Failure Risk in T2DM
An investigation explored associations between rapid kidney function decline and increased heart failure risk in individuals with type 2 diabetes.
Type 2 Diabetes With Microvascular Disease Increases Risk of Cardiovascular Death
A study was conducted to determine the effect of microvascular disease on cardiovascular morbidity and mortality in patients with type 2 diabetes.
Fracture Risk Up With Insulin Compared With Metformin in T2DM
Risk for major osteoporotic fractures up for insulin versus metformin for those with HbA1c <7 percent, BMI <25 kg/m2
Calciphylaxis Diagnosis and Management in Primary Care
Author reviews calciphylaxis incidence, risk factors, pathogenesis, differential diagnoses, and treatment.
AHA Releases Scientific Statement on Management of Cardiovascular Risk Factors in Type 2 Diabetes
The AHA released a statement focusing on the importance of managing cardiovascular risk factors in patients with type 2 diabetes.
Cardiac Events With Type 2 Diabetes, Kidney Disease Reduced With Finerenone
Chronic kidney disease increases the risk of cardiovascular events associated with type 2 diabetes. A clinical trial sought to discover if finerenone would help patients with both of these conditions.
SGLT2 Inhibitors Lead to Favorable Renal, CV Outcomes in Type 2 Diabetes
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
ADA: Tirzepatide Noninferior, Superior to Semaglutide for T2DM
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
- Loading...
Loading...
Next post in Diabetes
Loading... 
Loading...